• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 与肝脏疾病:全面更新。

HIV and liver disease: a comprehensive update.

机构信息

University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Top Antivir Med. 2022 Oct;30(4):547-558.

PMID:36375129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9681142/
Abstract

Despite substantial advances in the field, liver disease morbidity and mortality remain serious issues among people with HIV. The causes of liver disease are often multifactorial and include hepatitis viruses, hepatic steatosis and oxidative stress, bacterial translocation with activation of hepatic macrophages and stellate cells, and direct toxicities from alcohol and drugs of abuse. Biopsychosocial factors including a high prevalence of psychiatric disorders, food insecurity, insufficient access to care and medications, and social stigma all play roles in the persistence of liver injury and hepatic fibrosis development among people with HIV. Rising rates of hepatocellular carcinoma have been observed, suggesting that the epidemiology of liver disease is evolving.

摘要

尽管该领域取得了重大进展,但肝脏疾病的发病率和死亡率仍然是 HIV 感染者面临的严重问题。肝脏疾病的病因通常是多因素的,包括肝炎病毒、肝脂肪变性和氧化应激、细菌易位伴肝巨噬细胞和星状细胞激活,以及酒精和滥用药物的直接毒性。生物心理社会因素,包括精神障碍的高患病率、食物不安全、获得医疗和药物的机会不足,以及社会耻辱感,都在 HIV 感染者肝损伤和肝纤维化发展的持续存在中发挥作用。肝癌的发病率不断上升,表明肝脏疾病的流行病学正在发生变化。

相似文献

1
HIV and liver disease: a comprehensive update.HIV 与肝脏疾病:全面更新。
Top Antivir Med. 2022 Oct;30(4):547-558.
2
Free Access to Direct-Acting Antivirals in Spain: More Favorable Impact on Hepatitis C Mortality Among Highly Educated People.西班牙的直接作用抗病毒药物免费获取:对高学历人群丙型肝炎死亡率的更有利影响。
Clin Infect Dis. 2023 Apr 17;76(8):1423-1430. doi: 10.1093/cid/ciac928.
3
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.与 HCV 单感染患者相比,合并感染人类免疫缺陷病毒/丙型肝炎病毒(HCV)的肝硬化患者发生肝细胞癌或终末期肝病的风险不再更高。
Hepatology. 2019 Sep;70(3):939-954. doi: 10.1002/hep.30400. Epub 2019 Mar 15.
4
Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV.食物不安全与低收入、中年成年人的非酒精性脂肪肝和肝纤维化有关,无论是否感染 HIV。
Am J Clin Nutr. 2021 Mar 11;113(3):593-601. doi: 10.1093/ajcn/nqaa362.
5
Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals.在直接作用抗病毒药物治疗下,患有晚期纤维化的人类免疫缺陷病毒和丙型肝炎病毒感染者,在持续病毒学应答时的肝硬度可预测临床结局。
Clin Infect Dis. 2020 Dec 3;71(9):2354-2362. doi: 10.1093/cid/ciz1140.
6
Causes and outcomes of hepatic fibrosis in persons living with HIV.HIV 感染者肝纤维化的病因和转归。
Curr Opin HIV AIDS. 2022 Nov 1;17(6):359-367. doi: 10.1097/COH.0000000000000760. Epub 2022 Sep 12.
7
Liver fibrosis and fatty liver in Asian HIV-infected patients.亚洲 HIV 感染者的肝纤维化和脂肪肝。
Aliment Pharmacol Ther. 2016 Aug;44(4):411-21. doi: 10.1111/apt.13702. Epub 2016 Jun 15.
8
Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients.HIV感染患者中的肝炎病毒与肝细胞癌
Curr Opin Oncol. 2002 Sep;14(5):538-42. doi: 10.1097/00001622-200209000-00011.
9
Viral hepatitis in persons living with HIV in the post-COVID era.后 COVID 时代 HIV 感染者中的病毒性肝炎。
AIDS Rev. 2023;25(1):1-13. doi: 10.24875/AIDSRev.M23000061.
10
HIV and hepatitis C virus: special concerns for patients with cirrhosis.艾滋病毒和丙型肝炎病毒:肝硬化患者的特殊关注点。
J Infect Dis. 2013 Mar;207 Suppl 1:S40-4. doi: 10.1093/infdis/jis763.

引用本文的文献

1
HIV Infection and Antiretroviral Therapy Impair Liver Function in People Living with HIV: Systematic Review and Meta-Analysis.HIV感染及抗逆转录病毒疗法损害HIV感染者的肝功能:系统评价与荟萃分析
Pharmaceuticals (Basel). 2025 Jun 25;18(7):955. doi: 10.3390/ph18070955.
2
The role of liver macrophages in viral liver pathogenesis.肝脏巨噬细胞在病毒性肝病发病机制中的作用。
J Leukoc Biol. 2025 Sep 1;117(9). doi: 10.1093/jleuko/qiaf088.
3
Pharmacokinetics of islatravir in participants with moderate hepatic impairment.中度肝功能损害参与者中islatravir的药代动力学。
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0155324. doi: 10.1128/aac.01553-24. Epub 2025 Mar 5.
4
The Impact of Antiretroviral Therapy on Liver Function Among Pregnant Women Living with HIV in Co-Existence with and Without Pre-Eclampsia.抗逆转录病毒疗法对合并或未合并子痫前期的感染艾滋病毒孕妇肝功能的影响
Viruses. 2024 Dec 28;17(1):28. doi: 10.3390/v17010028.
5
Plasma proteomic profiles of patients with HIV infection and coinfection with hepatitis B/C virus undergoing anti‑retroviral therapy.接受抗逆转录病毒治疗的合并乙型/丙型肝炎病毒感染的HIV感染患者的血浆蛋白质组学图谱。
Biomed Rep. 2024 Aug 26;21(5):155. doi: 10.3892/br.2024.1843. eCollection 2024 Nov.
6
Association of cardiovascular disease risk with liver steatosis and fibrosis in people with HIV in low- and middle-income countries.低收入和中等收入国家HIV感染者中心血管疾病风险与肝脂肪变性和肝纤维化的关联
AIDS. 2025 Jan 1;39(1):11-21. doi: 10.1097/QAD.0000000000004012. Epub 2024 Sep 11.
7
Low Level Viremia Is Associated With Serious non-AIDS Events in People With HIV.低水平病毒血症与HIV感染者的严重非艾滋病事件相关。
Open Forum Infect Dis. 2024 Mar 30;11(4):ofae147. doi: 10.1093/ofid/ofae147. eCollection 2024 Apr.
8
Metabolic causes of liver disease among adults living with HIV from low- and middle-income countries: a cross-sectional study.中低收入国家 HIV 感染者的肝脏疾病代谢病因:一项横断面研究。
J Int AIDS Soc. 2024 Apr;27(4):e26238. doi: 10.1002/jia2.26238.
9
HIV-1 Myeloid Reservoirs - Contributors to Viral Persistence and Pathogenesis.HIV-1 髓系储库——病毒持续存在和发病机制的贡献者。
Curr HIV/AIDS Rep. 2024 Apr;21(2):62-74. doi: 10.1007/s11904-024-00692-2. Epub 2024 Feb 27.

本文引用的文献

1
Comorbidities among persons living with HIV (PLWH) in Florida: a network analysis.佛罗里达州 HIV 感染者共病情况:网络分析。
AIDS Care. 2023 Jul;35(7):1055-1063. doi: 10.1080/09540121.2022.2038363. Epub 2022 Feb 16.
2
Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct-acting antiviral therapies.直接作用抗病毒疗法问世后 HCV/HIV 合并感染患者肝移植结局的改善。
Transpl Infect Dis. 2022 Apr;24(2):e13808. doi: 10.1111/tid.13808. Epub 2022 Feb 28.
3
CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients.慢性 HIV/HCV 共感染患者的肝归巢 CCR5+ T 细胞表现出炎症和促纤维化特征。
Viruses. 2021 Oct 14;13(10):2074. doi: 10.3390/v13102074.
4
Serological response with Heplisav-B® in prior Hepatitis B vaccine non-responders living with HIV.在既往对乙型肝炎疫苗无应答的 HIV 感染者中,Heplisav-B®的血清学应答。
Vaccine. 2021 Oct 22;39(44):6529-6534. doi: 10.1016/j.vaccine.2021.09.050. Epub 2021 Sep 30.
5
Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART).在接受联合抗逆转录病毒疗法(cART)的HIV患者中对非酒精性脂肪性肝病(NAFLD)风险进行分层。
EClinicalMedicine. 2021 Sep 5;40:101116. doi: 10.1016/j.eclinm.2021.101116. eCollection 2021 Oct.
6
Translocated microbiome composition determines immunological outcome in treated HIV infection.移植微生物组组成决定了治疗后 HIV 感染的免疫结果。
Cell. 2021 Jul 22;184(15):3899-3914.e16. doi: 10.1016/j.cell.2021.05.023. Epub 2021 Jul 7.
7
Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis.可溶性CD163可识别肝脏炎症和纤维化加剧风险人群。
Open Forum Infect Dis. 2021 Apr 22;8(6):ofab203. doi: 10.1093/ofid/ofab203. eCollection 2021 Jun.
8
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.三抗原乙型肝炎疫苗与单抗原乙型肝炎疫苗在成人中的免疫原性和安全性(PROTECT):一项随机、双盲、III 期临床试验。
Lancet Infect Dis. 2021 Sep;21(9):1271-1281. doi: 10.1016/S1473-3099(20)30780-5. Epub 2021 May 11.
9
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.一项多中心随机对照试验的设计和方法,该试验评估了长效阿片类物质丁丙诺啡注射与传染病治疗相结合的综合护理模式,对象为因感染和阿片类药物使用障碍住院的患者。
Contemp Clin Trials. 2021 Jun;105:106394. doi: 10.1016/j.cct.2021.106394. Epub 2021 Apr 7.
10
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial.荷兰阿姆斯特丹的针具交换项目和阿片类激动剂治疗对注射吸毒者感染艾滋病毒、乙型肝炎和丙型肝炎病毒风险的影响:一项模拟目标试验的结果。
Addiction. 2021 Nov;116(11):3115-3126. doi: 10.1111/add.15503. Epub 2021 May 3.